Pharmacists can work alongside dermatologists, nurses, and other health care professionals to help answer skin care–related questions and help patients understand trial outcomes.
|Articles|September 7, 2021
Pharmacy Clinical Pearl of the Day: Psoriasis
Author(s)Saro Arakelians, PharmD
Psoriasis is a common, long-term chronic disease with no cure that goes through cycles, flaring for a few weeks or months, then going into remission.
Advertisement
Clinical Pearl of the Day: Psoriasis
Psoriasis is a skin disease that causes red, itchy, scaly patches, most commonly on the knees, elbows, trunk, and scalp.
Explanation:
- Psoriasis is a common, long-term chronic disease with no cure.
- It goes through cycles, flaring for a few weeks or months, then subsiding for a while or going into remission.
- Symptoms include: Red patches of skin covered with thick, silvery scales, small scaling spots (commonly seen in children), dry and cracked skin that may bleed or itch, burning or soreness, thickened and pitted or ridged nails, swollen and stiff joints.
- Types of psoriasis include plaque psoriasis, nail psoriasis, guttate psoriasis, inverse psoriasis, pustular psoriasis, erythrodermic psoriasis, psoriatic arthritis.
- Treatments include: corticosteroids, vitamin D analogues, retinoids, calcineurin inhibitors, salicylic acid, coal tar, Goeckerman therapy, and anthralin.
Reference:
Advertisement
Related to this article
OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
Nicole Albanese, PharmD, explains how a structured testing schedule and simple notes help patients bring useful glucose data to their care team.
Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
About 89% of Americans live within 5 miles of a pharmacy, but proximity says little about whether they can afford their medications or get real counseling.
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Getting patients vaccinated matters more than which COVID-19 vaccine they receive, says Jodi Longueil, PharmD.
The new agreement lets Hims & Hers patients obtain FDA-approved tirzepatide and orforglipron at Lilly’s self-pay prices.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
2
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
3
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
4
The Most Accessible Healthcare Professional—But Accessible to Whom?
5